Groundbreaking Malaria Vaccine under Test
Why in news?
- The World Health Organisation welcomed a pilot project in Malawi of administering a malaria vaccine to children below the age of 2 years. A total 3,60,000 children across three African countries — Malawi, Ghana and Kenya — will be covered every year with the vaccine.
What is the RTS, S (Mosquirix) vaccine?
- RTS, S/AS01 (trade name Mosquirix) is a recombinant protein-based malaria vaccine.
- A pilot project for vaccination has been launched on April 23, 2019 in Malawi. Ghana and Kenya are to join the program later this year.
- The vaccine has been developed by GSK (GlaxoSmithKline ) ....
Do You Want to Read More?
Subscribe Now
Take Annual Subscription and get the following Advantage
The annual members of the Civil Services Chronicle can read the monthly content of the magazine as well as the Chronicle magazine archives.
Readers can study all the material before the last six months of the Civil Services Chronicle monthly issue in the form of Chronicle magazine archives.
Related Content
- 1 Strengthening Food Security and Nutrition for an Inclusive India
- 2 Protecting Children in the Digital Age: The Need for Safer Social Media
- 3 India's Bioeconomy Blueprint: NITI Aayog's Roadmap to 2035
- 4 Vision Document on Drug Control
- 5 India's Rural Credit System: Expanding Financial Inclusion and Agricultural Growth
- 6 AI in India's Judicial System: Balancing Innovation with Constitutional Values
- 7 India’s Seaward Foreign Policy: Securing Maritime Interests in a Changing World
- 8 Fast Track Courts: Strengthening the Integrity of Public Examinations
- 9 Strategic Roadmap for Making Ayurveda Global
- 10 The Growing Threat of Antimicrobial Resistance in India
